Annual Cash & Cash Equivalents
$90.12 M
-$15.97 M-15.05%
31 December 2023
Summary:
AlloVir annual cash & cash equivalents is currently $90.12 million, with the most recent change of -$15.97 million (-15.05%) on 31 December 2023. During the last 3 years, it has fallen by -$32.54 million (-26.53%). ALVR annual cash & cash equivalents is now -55.31% below its all-time high of $201.66 million, reached on 31 December 2021.ALVR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$116.86 M
+$12.12 M+11.57%
30 September 2024
Summary:
AlloVir quarterly cash and cash equivalents is currently $116.86 million, with the most recent change of +$12.12 million (+11.57%) on 30 September 2024. Over the past year, it has increased by +$21.23 million (+22.20%). ALVR quarterly cash and cash equivalents is now -51.95% below its all-time high of $243.19 million, reached on 30 September 2021.ALVR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.1% | +22.2% |
| 3 y3 years | -26.5% | -52.0% |
| 5 y5 years | +306.0% | - |
ALVR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.3% | at low | -52.0% | +64.4% |
| 5 y | 5 years | -55.3% | +306.0% | -52.0% | +91.3% |
| alltime | all time | -55.3% | +306.0% | -52.0% | +91.3% |
AlloVir Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $116.86 M(+11.6%) |
| June 2024 | - | $104.74 M(+21.7%) |
| Mar 2024 | - | $86.04 M(-4.5%) |
| Dec 2023 | $90.12 M(-15.1%) | $90.12 M(-5.8%) |
| Sept 2023 | - | $95.63 M(-51.4%) |
| June 2023 | - | $196.95 M(+70.2%) |
| Mar 2023 | - | $115.70 M(+9.1%) |
| Dec 2022 | $106.09 M | $106.09 M(-14.3%) |
| Sept 2022 | - | $123.83 M(+74.2%) |
| June 2022 | - | $71.09 M(-29.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $100.21 M(-50.3%) |
| Dec 2021 | $201.66 M(+64.4%) | $201.66 M(-17.1%) |
| Sept 2021 | - | $243.19 M(+7.9%) |
| June 2021 | - | $225.45 M(+33.7%) |
| Mar 2021 | - | $168.65 M(+37.5%) |
| Dec 2020 | $122.66 M(+100.8%) | $122.66 M(-13.8%) |
| Sept 2020 | - | $142.25 M(+81.7%) |
| June 2020 | - | $78.27 M(+21.6%) |
| Mar 2020 | - | $64.38 M(+5.4%) |
| Dec 2019 | $61.08 M(+175.2%) | $61.08 M |
| Dec 2018 | $22.20 M | - |
FAQ
- What is AlloVir annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AlloVir?
- What is AlloVir annual cash & cash equivalents year-on-year change?
- What is AlloVir quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AlloVir?
- What is AlloVir quarterly cash and cash equivalents year-on-year change?
What is AlloVir annual cash & cash equivalents?
The current annual cash & cash equivalents of ALVR is $90.12 M
What is the all time high annual cash & cash equivalents for AlloVir?
AlloVir all-time high annual cash & cash equivalents is $201.66 M
What is AlloVir annual cash & cash equivalents year-on-year change?
Over the past year, ALVR annual cash & cash equivalents has changed by -$15.97 M (-15.05%)
What is AlloVir quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALVR is $116.86 M
What is the all time high quarterly cash and cash equivalents for AlloVir?
AlloVir all-time high quarterly cash and cash equivalents is $243.19 M
What is AlloVir quarterly cash and cash equivalents year-on-year change?
Over the past year, ALVR quarterly cash and cash equivalents has changed by +$21.23 M (+22.20%)